Xuan Liao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xuan Liao has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
Jia Lin
Department of Ophthalmology of Affiliated Hospital and Ophthalmology & Optometry of Medical School, North Sichuan Medical College, Nanchong, 637000, Sichuan Province, China
10 shared publications- Qing-Qing Tan
Department of Ophthalmology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China; Medical School of Ophthalmology & Optometry, North Sichuan Medical College, Nanchong, Sichuan, China
10 shared publications - Chang-Jun Lan
Department of Ophthalmology, Affiliated Hospital of North Sichuan Medical College, 1 Mao Yuan Nan Road, Nanchong, 637000, Sichuan, China.
8 shared publications Changjun Lan
Ophthalmology Department of Affiliated Hospital of North Sichuan Medical College, Medical School of Ophthalmology & Optometry, Nanchong, China
7 shared publicationsJing Tian
Department of Ophthalmology of Affiliated Hospital and Ophthalmology & Optometry of Medical School, North Sichuan Medical College, Nanchong, 637000, Sichuan Province, China
7 shared publicationsQingqing Tan
Department of Ophthalmology of Affiliated Hospital and Ophthalmology & Optometry of Medical School, North Sichuan Medical College, Nanchong, 637000, Sichuan Province, China
7 shared publications
Latest Publications
- 21 May 2026
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 124 (Pt 1) , 109124
Investigating pesticide-induced risk in high myopia-related retinal detachment: An integration of machine learning and molecular dynamics simulations
- 21 May 2026
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 124 (Pt 1) , 109124
Investigating pesticide-induced risk in high myopia-related retinal detachment: An integration of machine learning and molecular dynamics simulations
- Open Access
- 14 May 2026
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (7) , 101235
Re: Bai et al: Investigating the Shared Genetic Architecture of 3 Age-Related Ocular Disorders
- 14 May 2026
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (7) , 101235
Open AccessRe: Bai et al: Investigating the Shared Genetic Architecture of 3 Age-Related Ocular Disorders
- 10 April 2026
- Published by Elsevier in Clinical Therapeutics
- Vol. 48 (5) , 462-470
Pharmacological Management of Dry Eye Disease: A Contemporary Landscape Analysis
- 10 April 2026
- Published by Elsevier in Clinical Therapeutics
- Vol. 48 (5) , 462-470
Pharmacological Management of Dry Eye Disease: A Contemporary Landscape Analysis
- Open Access
- 8 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Exploration of brain function changes in the visual cortex of astigmatic subjects based on fNIRS
The primary objective of this research is to explore changes in brain activity among astigmatism patients, employing functional near-infrared spectroscopy (fNIRS). A prospective cross-sectional study comprising 57 participants (99 eyes) was conducted and segmented into three distinct sections. In PART I, 24 participants (48 eyes) with astigmatism (Group A) and 18 participants (36 eyes) without astigmatism (Group B) were assessed using fNIRS to investigate the variations across different brain regions and channels. PART II involved 15 participants with monocular astigmatism (15 eyes), who received complete spherical optical correction, followed by fNIRS assessments after visual stimulation using E-Prime software. The study examined the activation levels of the occipital visual cortex and the functional connectivity strength of the brain, comparing these metrics pre- and post-cylindrical correction. Following the correction of the initial refractive error in Group A, + 2.00 diopter cylinder (DC) lenses were employed to induce astigmatism at various axes. These axes were categorized into three groups: oblique astigmatism group, with-the-rule astigmatism (WTR), and against-the-rule astigmatism (ATR). fNIRS was conducted during task performance to assess the strength and activation level of brain functional connectivity across different astigmatism axes of the same diopter. The functional connectivity strength of HbO2-based occipital cortex was stronger in group B than in group A (P < 0.001). Significant differences in the β values of the left and right visual cortex were detected in cases of monocular astigmatism before and after astigmatism correction. (P = 0.002 and P = 0.004). The functional connectivity strength in the post-cylindrical correction condition exceeded that in the pre-cylindrical correction condition; nevertheless, this variation did not attain statistical significance (P > 0.05). The functional connectivity strength and activation level of the HbO2-based occipital visual cortex exhibited significant variations across different astigmatism axes (P < 0.001 and P = 0.045). Specifically, the functional connectivity strength in the oblique astigmatism group was greater than that observed in both the WTR and ATR groups. Conversely, the degree of brain activation in the oblique astigmatism group was lower compared to the ATR group (P = 0.042). These observations imply that astigmatism may decrease both the activation of the occipital visual cortex and the strength of brain functional connectivity. The functional activities of the occipital cortex can be enhanced to a certain degree following optical correction of astigmatism. The strength of functional connectivity and the degree of activation in the occipital visual cortex vary with different axes of astigmatism.Trial Registration This study was registered in the China Clinical Trials Registry (registration number: ChiCTR2300070613, date of registration: 2023-04-18), and the study followed the ethical principles required by the Declaration of Helsinki, and the subjects were informed and signed the informed consent form, and it has been reviewed and approved by the Medical Ethics Committee of the Affiliated Hospital of North Sichuan Medical College (Approval No. 2022ER541-1).
- 8 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessExploration of brain function changes in the visual cortex of astigmatic subjects based on fNIRS
The primary objective of this research is to explore changes in brain activity among astigmatism patients, employing functional near-infrared spectroscopy (fNIRS). A prospective cross-sectional study comprising 57 participants (99 eyes) was conducted and segmented into three distinct sections. In PART I, 24 participants (48 eyes) with astigmatism (Group A) and 18 participants (36 eyes) without astigmatism (Group B) were assessed using fNIRS to investigate the variations across different brain regions and channels. PART II involved 15 participants with monocular astigmatism (15 eyes), who received complete spherical optical correction, followed by fNIRS assessments after visual stimulation using E-Prime software. The study examined the activation levels of the occipital visual cortex and the functional connectivity strength of the brain, comparing these metrics pre- and post-cylindrical correction. Following the correction of the initial refractive error in Group A, + 2.00 diopter cylinder (DC) lenses were employed to induce astigmatism at various axes. These axes were categorized into three groups: oblique astigmatism group, with-the-rule astigmatism (WTR), and against-the-rule astigmatism (ATR). fNIRS was conducted during task performance to assess the strength and activation level of brain functional connectivity across different astigmatism axes of the same diopter. The functional connectivity strength of HbO2-based occipital cortex was stronger in group B than in group A (P < 0.001). Significant differences in the β values of the left and right visual cortex were detected in cases of monocular astigmatism before and after astigmatism correction. (P = 0.002 and P = 0.004). The functional connectivity strength in the post-cylindrical correction condition exceeded that in the pre-cylindrical correction condition; nevertheless, this variation did not attain statistical significance (P > 0.05). The functional connectivity strength and activation level of the HbO2-based occipital visual cortex exhibited significant variations across different astigmatism axes (P < 0.001 and P = 0.045). Specifically, the functional connectivity strength in the oblique astigmatism group was greater than that observed in both the WTR and ATR groups. Conversely, the degree of brain activation in the oblique astigmatism group was lower compared to the ATR group (P = 0.042). These observations imply that astigmatism may decrease both the activation of the occipital visual cortex and the strength of brain functional connectivity. The functional activities of the occipital cortex can be enhanced to a certain degree following optical correction of astigmatism. The strength of functional connectivity and the degree of activation in the occipital visual cortex vary with different axes of astigmatism.Trial Registration This study was registered in the China Clinical Trials Registry (registration number: ChiCTR2300070613, date of registration: 2023-04-18), and the study followed the ethical principles required by the Declaration of Helsinki, and the subjects were informed and signed the informed consent form, and it has been reviewed and approved by the Medical Ethics Committee of the Affiliated Hospital of North Sichuan Medical College (Approval No. 2022ER541-1).
- Open Access
- 2 March 2026
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 67 (3) , 24
On the Limited Predictive Value of Prior Myopia Progression: Methodological Considerations for Clinical Prediction
- 2 March 2026
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 67 (3) , 24
Open AccessOn the Limited Predictive Value of Prior Myopia Progression: Methodological Considerations for Clinical Prediction
- Open Access
- 12 January 2026
- Published by Elsevier in Ophthalmology
- Vol. 133 (5) , 668-679
Effect of Eye-Transcutaneous Electrical Acupoint Stimulation on Myopia Incidence in Children
- 12 January 2026
- Published by Elsevier in Ophthalmology
- Vol. 133 (5) , 668-679
Open AccessEffect of Eye-Transcutaneous Electrical Acupoint Stimulation on Myopia Incidence in Children
- 5 January 2026
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 40 (1) , 36
Identification of circadian rhythm-associated genes and therapeutic targets in myopia with dynamics simulation: a multiomics study using machine learning algorithms and Mendelian randomization
The prevalence of myopia is rising, with genetic and environmental factors playing key roles. Disruptions in circadian melatonin rhythms are also linked to refractive errors, though exact mechanisms remain unclear. Differential expression analysis on the GSE136701 dataset identified circadian-related genes. GSEA, GO, and KEGG analyses revealed key genes. To identify key genes, seven machine learning models were employed, and their performance was evaluated using ROC curve analysis. The correlation genes were further assessed. Concurrently, we performed a comprehensive analysis of immune infiltration and correlation pertaining to these pivotal genes. Additionally, potential target drugs were screened using the DSigDB database, and both protein-protein and molecular docking analyses were performed. To investigate the causal relationship between target genes and myopia, two-sample MR analysis was conducted. Finally, single-cell annotation and cell-cell communication analyses were carried out on the GSE235684 dataset. We preliminarily identified four circadian rhythm-related key genes: UTS2, BTBD9, S100A3, and LGALS9. We identified 8-Bromo-cAMP as the small molecule exhibiting the highest binding efficiency to BTBD9 and UTS2, with a docking binding energy of - 37.5 kcal/mol for the BTBD9-UTS2 complex and - 6.8 kcal/mol for the complex-small molecule interaction. The dynamics simulation analysis has further corroborated the dynamic stability of the UTS2-BTBD9 complex binding with 8-bromo-cAMP. Toxicological profiling of the selected small molecule 8-Bromo-cAMP was conducted using Protox-3.0 and ADMEtlab3.0. Additionally, Mendelian randomization analysis revealed a significant association between UTS2 and myopia, with an inverse variance weighted (IVW) P value of 0.013 (OR 0.532, 95% CI 0.323-0.877). Cochran's Q test revealed no significant heterogeneity in either MR-Egger (Q = 3.753, P = 0.289) or IVW (Q = 3.893, P = 0.421) estimates, supporting the use of fixed-effects models.
- 5 January 2026
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 40 (1) , 36
Identification of circadian rhythm-associated genes and therapeutic targets in myopia with dynamics simulation: a multiomics study using machine learning algorithms and Mendelian randomization
The prevalence of myopia is rising, with genetic and environmental factors playing key roles. Disruptions in circadian melatonin rhythms are also linked to refractive errors, though exact mechanisms remain unclear. Differential expression analysis on the GSE136701 dataset identified circadian-related genes. GSEA, GO, and KEGG analyses revealed key genes. To identify key genes, seven machine learning models were employed, and their performance was evaluated using ROC curve analysis. The correlation genes were further assessed. Concurrently, we performed a comprehensive analysis of immune infiltration and correlation pertaining to these pivotal genes. Additionally, potential target drugs were screened using the DSigDB database, and both protein-protein and molecular docking analyses were performed. To investigate the causal relationship between target genes and myopia, two-sample MR analysis was conducted. Finally, single-cell annotation and cell-cell communication analyses were carried out on the GSE235684 dataset. We preliminarily identified four circadian rhythm-related key genes: UTS2, BTBD9, S100A3, and LGALS9. We identified 8-Bromo-cAMP as the small molecule exhibiting the highest binding efficiency to BTBD9 and UTS2, with a docking binding energy of - 37.5 kcal/mol for the BTBD9-UTS2 complex and - 6.8 kcal/mol for the complex-small molecule interaction. The dynamics simulation analysis has further corroborated the dynamic stability of the UTS2-BTBD9 complex binding with 8-bromo-cAMP. Toxicological profiling of the selected small molecule 8-Bromo-cAMP was conducted using Protox-3.0 and ADMEtlab3.0. Additionally, Mendelian randomization analysis revealed a significant association between UTS2 and myopia, with an inverse variance weighted (IVW) P value of 0.013 (OR 0.532, 95% CI 0.323-0.877). Cochran's Q test revealed no significant heterogeneity in either MR-Egger (Q = 3.753, P = 0.289) or IVW (Q = 3.893, P = 0.421) estimates, supporting the use of fixed-effects models.
- Open Access
- 1 January 2026
- Published by Wiley in Depression and Anxiety
- Vol. 2026 (1) , 7344513
Depression and Depressive Symptoms in Glaucoma: A Systematic Review and Meta‐Analysis of Comparative, Prevalence, and Longitudinal Evidence
Background: Evidence suggests that people with glaucoma may experience more depressive symptoms than those without glaucoma, but prior estimates have been limited by heterogeneous ascertainment and insufficient separation of comparative, prevalence, and longitudinal evidence. Methods: We searched PubMed, Embase, Cochrane Library, Web of Science, SinoMed, Wanfang, VIP, CNKI, ChiCTR, and ClinicalTrials.gov to March 27, 2026. Eligible studies reported depression outcomes among individuals with glaucoma; studies included in the primary comparative analysis additionally required a non‐glaucoma comparison group. Two reviewers independently screened studies, extracted data, and assessed quality using the Newcastle–Ottawa Scale (NOS) for cohort/case‐control studies and Joanna Briggs Institute (JBI) tools for cross‐sectional studies. Random‐effects meta‐analyses used restricted maximum likelihood (REML) as the primary estimator; DerSimonian‐Laird models were sensitivity analyses. Certainty of evidence was assessed using the GRADE framework adapted for observational evidence. Results: Forty‐nine studies were included qualitatively. Sixteen studies including 14,030 glaucoma participants and 4,472,723 controls contributed to the primary odds ratio meta‐analysis. Glaucoma was associated with higher odds of depression (OR, 2.80; 95% CI, 1.66–4.74; I 2 = 95.95%; approximate prediction interval 0.32–24.47). Results remained significant across sensitivity analyses excluding self‐reported glaucoma studies, unclear glaucoma ascertainment, and a very large database study. Thirty‐eight studies including 21,705 patients with glaucoma contributed to the single‐group prevalence meta‐analysis; pooled depression prevalence was 26.03% (95% CI, 21.10%–31.64%; prediction interval 5.98%–66.04%). Longitudinal evidence was limited and heterogeneous; one UK Biobank cohort suggested a longitudinal association with incident hospitalized depression among participants with glaucoma (HR, 1.54; 95% CI, 1.01–2.34). GRADE certainty was very low for the comparative, prevalence, and longitudinal evidence domains. Conclusions: Very low‐certainty observational evidence suggests that depression or depressive symptoms are more common among individuals with glaucoma; however, whether glaucoma precedes, contributes to, or results from depressive symptoms remains uncertain. The observed association may reflect complex bidirectional relationships between glaucoma‐related visual burden and depressive symptoms. Ophthalmic care should incorporate pragmatic depression awareness and referral pathways, while future longitudinal studies should use standardized glaucoma and depression ascertainment with adequate adjustment for visual, clinical, and socioeconomic confounders.
- 1 January 2026
- Published by Wiley in Depression and Anxiety
- Vol. 2026 (1) , 7344513
Open AccessDepression and Depressive Symptoms in Glaucoma: A Systematic Review and Meta‐Analysis of Comparative, Prevalence, and Longitudinal Evidence
Background: Evidence suggests that people with glaucoma may experience more depressive symptoms than those without glaucoma, but prior estimates have been limited by heterogeneous ascertainment and insufficient separation of comparative, prevalence, and longitudinal evidence. Methods: We searched PubMed, Embase, Cochrane Library, Web of Science, SinoMed, Wanfang, VIP, CNKI, ChiCTR, and ClinicalTrials.gov to March 27, 2026. Eligible studies reported depression outcomes among individuals with glaucoma; studies included in the primary comparative analysis additionally required a non‐glaucoma comparison group. Two reviewers independently screened studies, extracted data, and assessed quality using the Newcastle–Ottawa Scale (NOS) for cohort/case‐control studies and Joanna Briggs Institute (JBI) tools for cross‐sectional studies. Random‐effects meta‐analyses used restricted maximum likelihood (REML) as the primary estimator; DerSimonian‐Laird models were sensitivity analyses. Certainty of evidence was assessed using the GRADE framework adapted for observational evidence. Results: Forty‐nine studies were included qualitatively. Sixteen studies including 14,030 glaucoma participants and 4,472,723 controls contributed to the primary odds ratio meta‐analysis. Glaucoma was associated with higher odds of depression (OR, 2.80; 95% CI, 1.66–4.74; I 2 = 95.95%; approximate prediction interval 0.32–24.47). Results remained significant across sensitivity analyses excluding self‐reported glaucoma studies, unclear glaucoma ascertainment, and a very large database study. Thirty‐eight studies including 21,705 patients with glaucoma contributed to the single‐group prevalence meta‐analysis; pooled depression prevalence was 26.03% (95% CI, 21.10%–31.64%; prediction interval 5.98%–66.04%). Longitudinal evidence was limited and heterogeneous; one UK Biobank cohort suggested a longitudinal association with incident hospitalized depression among participants with glaucoma (HR, 1.54; 95% CI, 1.01–2.34). GRADE certainty was very low for the comparative, prevalence, and longitudinal evidence domains. Conclusions: Very low‐certainty observational evidence suggests that depression or depressive symptoms are more common among individuals with glaucoma; however, whether glaucoma precedes, contributes to, or results from depressive symptoms remains uncertain. The observed association may reflect complex bidirectional relationships between glaucoma‐related visual burden and depressive symptoms. Ophthalmic care should incorporate pragmatic depression awareness and referral pathways, while future longitudinal studies should use standardized glaucoma and depression ascertainment with adequate adjustment for visual, clinical, and socioeconomic confounders.
- 5 November 2025
- Published by Elsevier in Ophthalmology Retina
- Vol. 10 (1) , e1
Re: Friedman et al: Randomized trial of biosimilar ABP 938 compared with reference aflibercept in adults with neovascular age-related macular degeneration (2025 Aug 5:S2468-6530(25)00351-3. doi: 10.1016/j.oret.2025.07.015. Online ahead of print.)
- 5 November 2025
- Published by Elsevier in Ophthalmology Retina
- Vol. 10 (1) , e1
Re: Friedman et al: Randomized trial of biosimilar ABP 938 compared with reference aflibercept in adults with neovascular age-related macular degeneration (2025 Aug 5:S2468-6530(25)00351-3. doi: 10.1016/j.oret.2025.07.015. Online ahead of print.)
- 17 October 2025
- Published by Elsevier in Ophthalmology
- Vol. 133 (1) , e5-e6
Re: Wang et al.: Myopia control efficacy of asymmetric multipoint defocus technique spectacle lenses: one-year double-masked randomized controlled trial (Ophthalmology. 2025;132:972–979)
- 17 October 2025
- Published by Elsevier in Ophthalmology
- Vol. 133 (1) , e5-e6
Re: Wang et al.: Myopia control efficacy of asymmetric multipoint defocus technique spectacle lenses: one-year double-masked randomized controlled trial (Ophthalmology. 2025;132:972–979)